206 related articles for article (PubMed ID: 2932382)
1. In vivo modulation of rat complement activities by infusion of anti-H antibodies.
Veerhuis R; van Es LA; Daha MR
Immunobiology; 1985 Sep; 170(3):133-45. PubMed ID: 2932382
[TBL] [Abstract][Full Text] [Related]
2. Surface modulation of classical pathway activation: C2 and C3 convertase formation and regulation on sheep, guinea pig, and human erythrocytes.
Brown EJ; Ramsey J; Hammer CH; Frank MM
J Immunol; 1983 Jul; 131(1):403-8. PubMed ID: 6602833
[TBL] [Abstract][Full Text] [Related]
3. Pathways of complement activation in membranoproliferative glomerulonephritis and allograft rejection.
Fearon DT; Daha MR; Strom TB; Weiler JM; Carpenter CB; Austen KF
Transplant Proc; 1977 Mar; 9(1):729-39. PubMed ID: 325806
[TBL] [Abstract][Full Text] [Related]
4. Mechanism of activation of the classical pathway of complement by monoclonal IgE (DES). Restricted regulation of C4b by C4b-binding protein.
Saint-Remy JM
Eur J Immunol; 1984 Mar; 14(3):254-9. PubMed ID: 6608450
[TBL] [Abstract][Full Text] [Related]
5. Alternative complement pathway activation by C4b deposited during classical pathway activation.
Matsushita M; Okada H
J Immunol; 1986 Apr; 136(8):2994-8. PubMed ID: 2937839
[TBL] [Abstract][Full Text] [Related]
6. Prevention of immune precipitation by purified components of the alternative pathway.
Naama JK; Holme E; Hamilton E; Whaley K
Clin Exp Immunol; 1985 Apr; 60(1):169-77. PubMed ID: 3159522
[TBL] [Abstract][Full Text] [Related]
7. Assembly of the membrane attack complex promotes decay of the alternative pathway C3 convertase on Neisseria gonorrhoeae.
Densen P; McRill CM; Ross SC
J Immunol; 1988 Dec; 141(11):3902-9. PubMed ID: 3141507
[TBL] [Abstract][Full Text] [Related]
8. Requirements for beta1H globulin and C3b inactivator in the control of the alternative complement pathway in human serum.
Whaley K; Thompson RA
Immunology; 1978 Dec; 35(6):1045-9. PubMed ID: 83964
[TBL] [Abstract][Full Text] [Related]
9. The functional inhibition of activated C1 inhibitor in normal human serum causes spontaneous consumption of the complement components C2, C3, C4, and factor B.
Gronski P; Bodenbender L; Kanzy EJ; Piepenbrock M; Seiler FR
Immunobiology; 1986 Apr; 171(3):252-62. PubMed ID: 3011651
[TBL] [Abstract][Full Text] [Related]
10. Stabilization of the amplification convertase of complement by monoclonal antibodies directed against human factor B.
Daha MR; Deelder AM; Van Es LA
J Immunol; 1984 May; 132(5):2538-42. PubMed ID: 6232321
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of alternative pathway and factor B haemolytic activities in patients with systemic lupus erythematosus: correlations with the alternative pathway regulatory proteins.
Aguado MT; Perrin LH; Ramirez R; Miescher PA; Lambert PH
Clin Exp Immunol; 1980 Dec; 42(3):495-505. PubMed ID: 6163579
[TBL] [Abstract][Full Text] [Related]
12. Control of C1 activation by nascent C3b and C4b: a mechanism of feedback inhibition.
Ziccardi RJ
J Immunol; 1986 May; 136(9):3378-83. PubMed ID: 3485688
[TBL] [Abstract][Full Text] [Related]
13. Protection of the classical and alternative complement pathway C3 convertases, stabilized by nephritic factors, from decay by the human C3b receptor.
Fischer E; Kazatchkine MD; Mecarelli-Halbwachs L
Eur J Immunol; 1984 Dec; 14(12):1111-4. PubMed ID: 6240408
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of immune precipitation by complement.
Hong K; Takata Y; Sayama K; Kozono H; Takeda J; Nakano Y; Kinoshita T; Inoue K
J Immunol; 1984 Sep; 133(3):1464-70. PubMed ID: 6747294
[TBL] [Abstract][Full Text] [Related]
15. Cigarette smoke can activate the alternative pathway of complement in vitro by modifying the third component of complement.
Kew RR; Ghebrehiwet B; Janoff A
J Clin Invest; 1985 Mar; 75(3):1000-7. PubMed ID: 3156879
[TBL] [Abstract][Full Text] [Related]
16. Activation of the alternative pathway of the complement system by radiographic contrast media.
Arroyave CM; Bhat KN; Crown R
J Immunol; 1976 Nov; 117(5 Pt.2):1866-9. PubMed ID: 993582
[TBL] [Abstract][Full Text] [Related]
17. Complement activation and complement control proteins in acute pancreatitis.
Whicher JT; Barnes MP; Brown A; Cooper MJ; Read R; Walters G; Williamson RC
Gut; 1982 Nov; 23(11):944-50. PubMed ID: 6922819
[TBL] [Abstract][Full Text] [Related]
18. [Formation of classical C3 convertase during the alternative pathway of human complement activation].
Kozlov LV; Shibanova ED; Zinchenko AA
Biokhimiia; 1987 Apr; 52(4):660-6. PubMed ID: 3647798
[TBL] [Abstract][Full Text] [Related]
19. Human monocyte spreading induced by factor Bb of the alternative pathway of complement activation. A possible role for C5 in monocyte spreading.
Sundsmo JS; Götze O
J Exp Med; 1981 Sep; 154(3):763-77. PubMed ID: 6912276
[TBL] [Abstract][Full Text] [Related]
20. EAC4 and EAC14 production without purified Ci.
Linscott WD
J Immunol; 1975 Dec; 115(6):1625-30. PubMed ID: 241767
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
